ALICIA CLARK: Open Payments
NPI 1821469537 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$604 in 27 payments from 12 companies in 2025. Trend: 2023 $533 · 2024 $203 · 2025 $604
Food & beverage: $604
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $192 |
| E.R. Squibb & Sons, L.L.C. | 4 | $95 |
| GE HEALTHCARE | 2 | $65 |
| BridgeBio Pharma, Inc. | 2 | $55 |
| Inspire Medical Systems, Inc. | 1 | $54 |
| PFIZER INC. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| GENZYME CORPORATION | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Edwards Lifesciences Corporation | 1 | $19 |
Products named: LEQVIO, ELIQUIS, Attruby, INSPIRE, CAMZYOS, AMVUTTRA, FABRAZYME, Kerendia.
Industry payments across CO — which companies pay providers there.
